Back to User profile » Dr Jie Peng
Papers published by Dr Jie Peng:
Estimated Pulse Wave Velocity as a Novel Non-Invasive Biomarker for Metabolic Syndrome Among People Living with HIV
Chen S, Jiang Y, Lin X, Chen H, Wu X, Qian Z, Xu X, Zhong H, Peng J, Cai S
Diabetes, Metabolic Syndrome and Obesity 2024, 17:1999-2010
Published Date: 13 May 2024
Factors Associated with Mortality Among Severe Omicron Patients for COVID-19
Wu S, Liao G, Mao J, Yan H, Chen J, Peng J
Infection and Drug Resistance 2024, 17:1309-1319
Published Date: 3 April 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued
Liao G, Liu Z, Xia M, Chen H, Wu H, Li B, Yu T, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2022, 15:2347-2357
Published Date: 29 April 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J
International Journal of General Medicine 2022, 15:407-415
Published Date: 10 January 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Association Between Nutritional Risk Screening Score and Prognosis of Patients with Sepsis
Gao Q, Cheng Y, Li Z, Tang Q, Qiu R, Cai S, Xu X, Peng J, Xie H
Infection and Drug Resistance 2021, 14:3817-3825
Published Date: 17 September 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
Liao G, Ding X, Xia M, Wu Y, Chen H, Fan R, Zhang X, Cai S, Peng J
International Journal of General Medicine 2021, 14:4967-4976
Published Date: 28 August 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog
Ji X, Xia M, Zhou B, Liu S, Liao G, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2020, 13:1881-1888
Published Date: 22 June 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs
Cai S, Li Z, Yu T, Xia M, Peng J
Infection and Drug Resistance 2018, 11:469-477
Published Date: 3 April 2018
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study
Peng J, Yin JH, Cai SH, Yu T, Zhong CX
Patient Preference and Adherence 2015, 9:41-45
Published Date: 7 January 2015